A million doses from the Indian company already delivered have been sold on to other countries in the African Union.
This comes after govt panel visits facilities of SII and Bharat Biotech
The petitioner, 41-year old Asif Riaz, also sought an interim injunction restraining the Central government and the Drugs Controller General of India from continuing with administering Covishield
Cairn Energy has filed a case in a US district court to enforce a $1.2 billion arbitration award it won in a tax dispute against India, a court document showed. Read top news with Business Standard
Adar Poonawalla-controlled Rising Sun Holdings will acquire a 60 per cent stake in non-banking financial company by subscribing to Rs 3,456-crore preferential issue
Home-grown firms get new orders: 10 million for SII, 4.5 million for Bharat Bio
"Both the companies have written to the DCGI regarding changing this point and that will happen very soon," Bhargava said
All were construction workers whose bodies were recovered by fire brigade personnel from the fifth floor, police said, adding nine others were evacuated from the spot.
Business Standard brings you top news of the evening
Serum, the world's largest producer of vaccines by volume, can ship out the Astra vaccine priced between $5-10 per dose
Serum Institute of India (SII) is manufacturing anti-coronavirus vaccine called ''Covishield''
Two deaths were reported in Uttar Pradesh and Karnataka, one not linked to jab, the other yet to be investigated
Serum Institute already has two deals of 100 million each to supply the Oxford-AstraZeneca and the Novavax vaccine to Gavi-Covax at $3 per dose
The health ministry is prepared to roll out the Covid vaccine within 10 days of the emergency use authorisation, which was granted to two companies on January 3
Other vaccines being developed in India, dangerous conspiracy theories, private hospitals keen on jumping in-news relevant to India's fight against Covid-19
Delhi Chief Minister Arvind Kejriwal said that approval for the emergency use of two "made in India" vaccines will give a positive direction to the country's fight against coronavirus
Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca COVID-19 vaccine 'Covishield' is ready to roll out in the coming weeks. Poonawalla's remarks came soon after after India's drugs regulator approved Covishield for restricted emergency use. "Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks," Poonawalla tweeted. "Thank you Hon. Sri @narendramodi Ji, Hon. Sri @drharshvardhan Ji, @MoHFW_INDIA @ICMRDELHI @DBTIndia #DCGI_India @UniofOxford @AstraZeneca @gavi @GaviSeth @gatesfoundation and @BillGates for your support," he added.
First deliveries are expected to begin in the first quarter of 2021 depending upon regulatory approvals and readiness of countries for delivery
In all, 29,000 cold chain points, 240 walk-in coolers, 70 walk-in freezers, 45,000 ice-lined refrigerators, 41,000 deep freezers and 300 solar refrigerators are to be used
Serum Institute of India, the world's largest vaccine maker, is already mass producing and stockpiling AstraZeneca's Covishield shot